Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Sotera"


11 mentions found


David Einhorn's Greenlight Capital this week revealed a fresh stake in agriculture equipment maker CNH Industrial , and increased its bets on Peloton Interactive and gold in the third quarter. The hedge fund, which Einhorn founded in 1996, disclosed in its latest regulatory filing that it took a roughly $79 million stake in CNH during the latest quarter. Einhorn also increased his holding in Peloton by roughly 40%, bringing his stake in the company to about $45 million. That led him to buy medium-sized stakes in a few value companies and take a larger position in gold. Einhorn added 3.1% to his holding in SPDR Gold Trust in the most recent quarter, bringing it to $51 million.
Persons: David Einhorn's, Einhorn Organizations: Interactive, CNBC, CNBC's, Alpha, Robin Hood Investors Conference, Cornell, Trust, Capri Holdings, Penn Entertainment, HP, Roivant Sciences, Packaging, Tenet Healthcare Locations: CNH, Holland, New York City, Capri
Another year, another lousy IPO market. The 2023 IPO market is closing with a whimper, not a bang. You'd think the IPO market would be bubbling, but it's dead quiet. Source: Renaissance Capital For a good part of the year, the excuse was interest rates were rising, the market was too volatile, and the after market performance of 2023 IPOs was terrible. The November rally is too little too late to save the IPO market Unfortunately, it all came a little too late to rescue 2023.
Persons: Birkenstock, You'd, Rivian, Doordash, IPOs, Matt Kennedy, Don Short, you've, haven't, confidentially, Waystar, Kim Kardashian's, Musk, Howe Ng, Ng, Kyle Stanford, Instacart, it's, James Ulan, Stanford, Pitchbook, Greg Martin Organizations: Renaissance, That's, IPOs, Hertz, Sotera, ARM, Renaissance Capital, Klarna, Microsoft, Forge Global, Bloomberg, SpaceX, Nvidia, Rainmaker Securities Locations: Pitchbook
David Einhorn's Greenlight Capital made several bets in energy and health care during the third quarter, according to a new securities filing. That position was worth $65.2 million. Greenlight also bought up shares in biotech names Gain Therapeutics and Coya Therapeutics , increasing those stakes by 7.7% and 19.2%, respectively. The fund's largest position, homebuilding stock Green Brick Partners , was worth more than $512 million as of the end of September. Greenlight has soared past the broader market this year, returning 12.9% in the third quarter to bring its 2023 gains to more than 27%.
Persons: David Einhorn's, Einhorn, Russia's, Greenlight Organizations: Holdings, Securities, Exchange, Southwestern Energy, Consol Energy, Therapeutics, Coya Therapeutics, Green Brick Partners, Kyndryl Holdings Locations: Israel, Ukraine, U.S
"That was a big wet blanket" for the IPO market, Greg Martin from Rainmaker Securities told me. Buy now, pay later firm Klarna, another oft-mentioned IPO candidate, told CNBC it has no immediate plans to go public. This is in stark contrast to most years, when big IPOs went public in November and December. A month earlier, in November 2020, Sotera Health raised $1.1 billion, and Miravai Life Sciences raised $1.6 billion. By contrast, a normal year should see at least $50 billion raised.
Persons: Don Short, Matt Kennedy, Greg Martin, IPOs, Klarna, Rivian, Hertz, Braze, Sweetgreen, Allbirds, Airbnb, Doordash, it's fizzling, Instacart, Kennedy, Homebuilder Smith Douglas, Morgan Stanley, there's Organizations: New York Stock Exchange, NYSE, Renaissance Capital, Rainmaker Securities, Wall Street Journal, CNBC, Bloomberg, Sciences, Renaissance, That's, IPOs, Healthcare Locations: Cava, U.S
Accenture — The stock fell 2.6% after the consulting firm shaved the top end of its revenue expectations for the fiscal year. Darden posted earnings of $2.58 per share on revenue of $2.77 billion in its latest quarter. Tesla — Tesla shares traded flat amid a choppy session after Morgan Stanley downgraded the electric-vehicle giant to an equal weight rating from overweight, citing valuation concerns. Loop also reiterated its buy rating and raised its price target given what it sees as an opportunity for the stock to rally further. Expedia , TripAdvisor — Expedia and TripAdvisor gained 1.5% and 3.2%, respectively, after B. Riley initiated coverage on each stock as buy.
Persons: AeroSystems, Max, Darden, Eugene Lee, influencer Dylan, Tesla, Morgan Stanley, Root, JPMorgan Chase, Dow, , TripAdvisor, Riley, Expedia, Eli Lilly —, Samantha Subin, Michelle Fox, Jesse Pound Organizations: Bed, Boeing, Accenture, Darden, FactSet, Anheuser, Busch InBev —, Deutsche Bank, NRG Energy, Wall Street, Elliott Investment Management, Embedded Insurance, Alcoa, JPMorgan, Amazon Prime, Bank of America Locations: Salt Lake City , Utah, Wichita , Kansas, Illinois
A Boeing 737 MAX 8 sits outside the hangar during a media tour of the Boeing 737 MAX at the Boeing plant in Renton, Washington. Oak Street Health – Shares of Oak Street Health surged 36% after a Bloomberg report that CVS is exploring options to buy the health care company for more than $10 billion. Frontline –The shipping stock surged more than 24% in premarket trading after Frontline announced that it was terminating its combination with Euronav. Boeing — The aerospace giant fell more than 2% after Morgan Stanley downgraded Boeing to equal weight from overweight, citing a lack of potential upside from current levels. Meanwhile, the firm upgraded competitor Royal Carribean, which added 0.3% in the premarket, to equal weight from underweight.
Discovery — Shares of the media company jumped more than 6% after Bank of America added the stock to the "US1" list. Coinbase — Shares jumped almost 6% after the cryptocurrency exchange shared plans to trim its workforce by 20%. Bed Bath & Beyond — The retailer jumped nearly 19%. Frontline — Shares of the shipping company jumped 26% after Frontline announced that it was terminating a deal to combine with Euronav. Agilent Technologies — Shares rose more than 4% a day after the company announced a $2 billion share repurchase program.
Jim Cramer gives his take on Clearfield and Sotera Health
  + stars: | 2022-12-14 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJim Cramer gives his take on Clearfield and Sotera HealthCramer offered his thoughts on the two companies and their stocks on Wednesday.
Loading chart...Church & Dwight Co Inc : "I've got to tell you, some of the other growth stocks in the same category I might as well [buy instead]. Smucker , that's a very good company. I think it's a little bit cheaper." Loading chart...Lumen Technologies Inc : "I don't understand why they're doing this badly." Camping World Holdings Inc : "I say it's fine to buy."
The Clarkston Founders Institutional Fund has always tried to avoid volatility. The Founder's Fund has lost about 2.8% in 2022, notably outperforming other mid-cap value funds, which are down an average 7.2%, and a Morningstar benchmark index, which is lower by 5.6%, all through Dec. 9. As a result, the $610-million fund has a below average beta — a measurement of volatility relative to the broad market — of 0.85, according to Morningstar, versus 1.08 for all mid-cap value funds. The fund ranks in the 15th percentile of all mid-cap value funds in 2022, and is in the 23rd percentile over the past five years. Clarkston's investment policy emphasizes what it calls "quality value" stocks, regarded as high quality and considered undervalued relative to their long-term cash flows.
Stitch Fix — Stitch Fix was up about 12%, even after the company posted downbeat quarterly numbers. General Mills — Shares of the food producer jumped 7% after the company posted a better-than-expected quarterly profit. The company now sees adjusted EBITDA between $1.4 billion and $1.45 billion, below prior guidance of $1.475 billion and $1.575 billion. Sotera Health — Sotera Health shares dropped more than 7% after JPMorgan downgraded the company to underweight from overweight, citing risks from more than 700 outstanding trials. Coty — The stock rose 5.6% after the beauty company said it has a strategy to double skincare product sales by fiscal year 2025.
Total: 11